In vivo angiogenic activity of urokinase: role of endogenous fibroblast growth factor-2

QUICK SEARCH:

[advanced]

	Author:		Keyword(s):

Home Help Feedback Subscriptions Archive Search Table of Contents

This Article

	Summary
	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted

Services

	Email this article to a friend
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Download to citation manager


Citing Articles

	Citing Articles via HighWire
	Citing Articles via Google Scholar

Google Scholar

	Articles by Ribatti, D.
	Articles by Presta, M.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Ribatti, D.
	Articles by Presta, M.


Social Bookmarking

	What's this?

Astedt, B. and Trope, C (1980). Effect of tranexamic acid on progress of experimental tumours and on DNA synthesis. Experientia 36, 679-680.[Medline]

Avery, R. L., Connor, T. B. and Farazdaghi, M (1990). Systemic amiloride inhibits experimentally induced neovascularization. Arch. Ophtalmol 108, 1474-1476.

Bacharach, E., Itin, A. and Keshet, E (1992). In vivo patterns of expression of urokinase and its inhibitor PAI-1 suggest a concerted role in regulating physiological angiogenesis. Proc. Nat. Acad. Sci. USA 89, 10686-10690.[Abstract/Free Full Text]

Bashkin, P., Doctrow, S., Klagsbrun, M., Svahn, C. M., Folkman, J. and Vlodavsky, I (1989). Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules. Biochemistry 28, 1737-1743.[Medline]

Basilico, C. and Moscatelli, D (1992). The FGF family of growth factors and oncogenes. Advan. Cancer Res 59, 115-165.[Medline]

Berman, M., Winthrop, S., Ausprunk, D., Rose, J., Langer, R. and Gage, J (1982). Plasminogen activator (urokinase) causes vascularization of the cornea. Invest. Ophthalmol. Vis. Sci 22, 191-199.[Abstract/Free Full Text]

Behrendt, N., Ronne E. and Dano, K (1993). Binding of the urokinase-type plasminogen activator to its cell surface receptor is inhibited by low doses of suramin. J. Biol. Chem 268, 5985-5989.[Abstract/Free Full Text]

Brooks, P. C., Clark, R. A. F. and Cheresh, D. A (1994). Requirement of vascular integrinv 3for angiogenesis. Science 264, 569-571.[Abstract/Free Full Text]

Bugge, T. H., Flick, M. J., Daugherty, C. C. and Degen, J. L (1995). Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. Genes Dev 9, 794-807.[Abstract/Free Full Text]

Bussolino, F., Di Renzo, M. F., Ziche, M., Bocchietto, E., Olivero, M., Naldini, L., Gaudino, G., Tamagnone, L., Coffer, A. and Comoglio, P. M (1992). Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J. Cell Biol 119, 629-641.[Abstract/Free Full Text]

Carmeliet, P., Schoonjans, L., Kieckens, L., Ream, B., Degen, J., Bronson, R., De Vos, R., van den Oord, J. J., Collen, D. and Mulligan, R. C (1994). Physiological consequences of loss of plasminogen activator gene function in mice. Nature 368, 419-424.[Medline]

Coltrini, D., Rusnati, M., Zoppetti, G., Oreste, P., Isacchi, A., Caccia, P., Bergonzoni, L. and Presta, M (1993). Biochemical bases of the interaction of human fibroblast growth factor with glycosaminoglycans. Eur. J. Biochem 214, 51-58.[Medline]

Corasanti, J. G., Hobika, G. H. and Markus, G (1982). Interference with dimethylhydrazine induction of colon tumors in mice by-aminocaproic acid. Science 216, 1020-1021.[Abstract/Free Full Text]

Corti, A., Sarubbi, E., Soffientini, A., Nolli, M. L., Zanni, A., Galimberti, M., Parenti, E. and Cassani, G (1989). Epitope mapping of the anti-urokinase monoclonal antibody 5B4 by isolated domains of urokinase. Thromb. Haemostas 62, 934-939.[Medline]

De Petro, G., Copeta, A. and Barlati, S (1994). Urokinase-type and tissue-type plasminogen activators as growth factors of human fibroblasts. Exp. Cell Res 213, 286-294.[Medline]

DiMario, J., Buffinger, N., Yamada, S. and Strohman, R. C (1989). Fibroblast growth factor in the extracellular matrix of dystrophic (mdx) mouse muscle. Science 244, 688-690.[Abstract/Free Full Text]

Estreicher, A., Wohlwend, A., Belin, D., Schleuning, W. D. and Vassalli, J.-D (1989). Characterization of the cellular binding site for the urokinase-type plasminogen activator. J. Biol. Chem 264, 1180-1189.[Abstract/Free Full Text]

Falcone, D. J., McCaffrey, T. A., Haimovitz-Friedman, A., Vergilio, J.-A. and Nicholson, A (1993). Macrophage and foam cell release of matrix-bound growth factors. Role of plasminogen activation. J. Biol. Chem 268, 11951-11958.[Abstract/Free Full Text]

Fibbi, G., Caldini, R., Chevanne, M., Pucci, M., Schiavone, N., Morbidelli, L., Parenti, A., Granger, H. J., Del Rosso, M. and Ziche, M (1998). Urokinase-dependent angiogenesis in vitro and diacylglycerol production are blocked by antisense oligonucleotides against the urokinase receptor. Lab. Invest 78, 1109-1119.[Medline]

Flaumenhaft, R., Moscatelli, D. and Rifkin, D. B (1990). Heparin and heparan sulfate increase the radius of diffusion and action of basic fibroblast growth factor. J. Cell Biol 111, 1651-1659.[Abstract/Free Full Text]

Folkman, J., Klagsbrun, M., Sasse, J., Wadzinsky, M., Ingber, D. and Vlodavsky, I (1988). A heparin-binding angiogenic protein-basic fibroblast growth factor is stored within basement membrane. Am. J. Pathol 130, 393-400.[Abstract]

Gospodarowicz, D. and Cheng, J (1986). Heparin protects basic and acidic FGF from inactivation. J. Cell. Physiol 128, 175-184.

Gualandris, A. and Presta, M (1995). Transcriptional and post-transcriptional regulation of urokinase-type plasminogen activator expression in endothelial cells by basic fibroblast growth factor. J. Cell. Physiol 162, 400-409.[Medline]

Gualandris, A., Conejo, T. L., Giunciuglio, D., Albini, A., Sabini, E., Rusnati, M., Dell'Era, P. and Presta, M (1997). Urokinase-type plasminogen activator overexpression enhances the invasive capacity of endothelial cells. Microvasc. Res 53, 254-260.[Medline]

Hageman, G. S., Kirchoff-Rempe, M. A., Lewis, G. P., Fisher, S. K. and Anderson, D. H (1991). Sequestration of basic fibroblast growth factor in the primate retinal interphotoreceptor matrix. Proc. Nat. Acad. Sci. USA 88, 6706-6710.[Abstract/Free Full Text]

Iruela-Arispe, M. L., Lane, T. F., Redmond, D., Reilly, M., Bolender, R. P., Kavanagh, T. J. and Sage, E. H (1995). Expression of SPARC during development of the chicken chorioallantoic membrane: evidence for regulated proteolysis in vivo. Mol. Biol. Cell 6, 327-343.[Abstract]

Johnson, D. E. and Williams, L. T (1993). Structural and functional diversity in the FGF receptor multigene family. Advan. Cancer Res 60, 1-41.[Medline]

Koolwijk, P., van Erck, M. G. M., de Vree, W. J. A., Vermeer, M. A., Weich, H. A., Hanemaaijer, R. and van Hinsbergh, V. W. M (1996). Cooperative effect of TNF, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity. J. Cell Biol 132, 1177-1188.[Abstract/Free Full Text]

Mandriota, S. J., Seghezzi, G., Vassalli, J-D., Ferrara, N., Wasi, S., Mazzieri, R., Mignatti, P. and Pepper, M (1995). Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells. J. Biol. Chem 270, 9709-9716.[Abstract/Free Full Text]

Mignatti, P. and Rifkin, D. B (1993). Biology and biochemistry of proteinases in tumor invasion. Physiol. Rev 73, 161-195.[Free Full Text]

Mignatti, P., Tauboi, R., Robbins, E. and Rifkin, D. B (1989). In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor. J. Cell Biol 108, 671-682.[Abstract/Free Full Text]

Mignatti, P., Mazzieri, R. and Rifkin, D. B (1991). Expression of the urokinase receptor in vascular endothelial cells is stimulated by basic fibroblast growth factor. J. Cell Biol 113, 1193-1201.[Abstract/Free Full Text]

Moscatelli, D (1986). Urokinase-type and tissue-type plasminogen activators have different distributions in cultured bovine capillary endothelial cells. J. Cell. Biochem 30, 19-29.[Medline]

Nguyen, M., Shing, Y. and Folkman, J (1994). Quantitation of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane. Microvasc. Res 47, 31-40.[Medline]

Oh, S. J., Jeltsch, M. M., Birkenhager, R., McCarthy, J. E., Weiche, H. A., Christ, B., Alitalo, K. and Wilting, J (1997). VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev. Biol 188, 96-109.[Medline]

Pepper, M. S., Ferrara, N., Orci, L. and Montesano, R (1991). Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem. Biophys. Res. Commun 181, 902-906.[Medline]

Pepper, M. S., Montesano, R., Mandriota, S., Orci, L. and Vassalli, J.-D (1996). Angiogenesis: a paradigm for balanced extracellular proteolysis during cell migration and morphogenesis. Enzyme Protein 49, 138-162.[Medline]

Presta, M., Maier, J. A. M., Rusnati, M. and Ragnotti, G (1989). Basic fibroblast growth factor is released from endothelial extracellular matrix in a biologically active form. J. Cell. Physiol 140, 68-74.[Medline]

Ribatti, D., Urbinati, C., Nico, B., Rusnati, M., Roncali, L. and Presta, M (1995). Endogenous basic fibroblast growth factor is implicated in the vascularization of the chick embryo chorioallantoic membrane. Dev. Biol 170, 39-49.[Medline]

Ribatti, D., Gualandris, A., Bastaki, M., Vacca, A., Roncali, L. and Presta, M (1997). A new model for the study of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane (CAM): the gelatin sponge/CAM assay. J. Vasc. Res 34, 455-463.[Medline]

Ribatti, D., Bertossi, M., Nico, B., Vacca, A., Ria, R., Riva, A., Roncali, L. and Presta, M (1998). Role of the basic fibroblast growth factor in the formation of the capillary plexus in the chick embryo chorioallantoic membrane. An in situ hybridization, immunohistochemical and ultrastructural study. J. Submicrosc. Cytol. Pathol 30, 127-136.[Medline]

Rogelj, S., Klagsbrun, M., Atzmon, R., Kurokawa, M., Haimovitz, A., Fuks, Z. and Vlodavsky, I (1989). Basic fibroblast growth factor is an extracellular matrix component required for supporting the proliferation ofvascular endothelial cells and the differentiation of PC12 cells. J. Cell Biol 109, 823-831.[Abstract/Free Full Text]

Rusnati, M. and Presta, M (1996). Interaction of angiogenic basic fibroblast growth factor with endothelial cell heparan sulfate proteoglycans. Int. J. Clin. Lab. Res 26, 15-23.[Medline]

Rusnati, M., Urbinati, C. and Presta, M (1993). Internalization of basic fibroblast growth factor (bFGF) in cultured endothelial cells: role of the low affinity heparin-like bFGF receptors. J. Cell. Physiol 154, 152-161.[Medline]

Sabapathy, K. T., Pepper, M. S., Keifer, F., Mohle-Steinlein, U., Tacchini-Cottier, F., Fetka, I., Breier, G., Risau, W., Carmeliet, P., Montesano, R. and Wagner, E. F (1997). Polyoma middle T-induced vascular tumor formation: the role of the plasminogen activator/plasmin system. J. Cell Biol 137, 953-963.[Abstract/Free Full Text]

Saksela, O. and Rifkin, D. B (1988). Cell-associated plasminogen activation: regulation and physiological functions. Annu. Rev. Cell Biol 4, 93-126.

Saksela, O. and Rifkin, D. B (1990). Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity,. J. Cell Biol 110, 767-775.[Abstract/Free Full Text]

Salonen, E.-M., Tervo, T., Torma, E., Tarkkanen, A. and Vaheri, A (1987). Plasmin in tear fluid of patients with chronic ulcers. Basis for new therapy. Acta Ophthalmol 65, 17-24.

Tamura, T., Nakanishi, T., Kimura, Y., Hattori, T., Sasaki, K., Norimatsu, H., Takahashi, K. and Takigawa, M (1996). Nitric oxide mediates interleukin-1-induced matrix degradation and basic fibroblast growth factor release in cultured rabbit articular chondrocytes: a possible mechanism of pathological neovascularization in arthritis. Endocrinology 137, 3729-3737.[Abstract]

Teuscher, E. and Pester, E (1984). A possible explanation of mechanisms inducing inhibition of vascularization of tumours by antifibrinolytic drugs: the influence of migratory behaviour of endothelial cells. Biomed. Biochim. Acta 43, 447-456.[Medline]

Tsopanoglou, N. E., Pipili-Synetos, E. and Maragoudakis, M. E (1993). Thrombin promotes angiogenesis by a mechanism independent of fibrin formation. Am. J. Physiol 265, 1302-1307.

Vlodavsky, I., Folkman, J., Sullivan, R., Fridman, R., Ishai-Michaeli, R., Sasse, J. and Klagsbrun, M (1987). Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. Proc. Nat. Acad. Sci. USA 84, 2292-2296.[Abstract/Free Full Text]

Whitelock, J. M., Murdoch, A. D., Iozzo, R. V. and Underwood, P. A (1996). The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin and heparanase. J. Biol. Chem 271, 10079-10086.[Abstract/Free Full Text]

Yasunaga, C., Nakashima, Y. and Sueishi, K (1989). A role of fibrinolytic activity in angiogenesis. Quantitative assay using in vitro method. Lab. Invest 61, 698-704.[Medline]

Ziche, M., Maglione, D., Ribatti, D., Morbidelli, L., Lago, C. T., Battisti, M., Paoletti, I., Barra, A., Tucci, M., Parise, G., Vincenti, V., Granger, H. J., Viglietto, G. and Persico, M. G (1997). Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic. Lab. Invest 76, 517-531.[Medline]

CiteULike

Complore

Connotea

Del.icio.us Add to Digg

Digg

Technorati

Twitter What's this?

This article has been cited by other articles:

V. C. Ardi, P. E. Van den Steen, G. Opdenakker, B. Schweighofer, E. I. Deryugina, and J. P. Quigley
Neutrophil MMP-9 Proenzyme, Unencumbered by TIMP-1, Undergoes Efficient Activation in Vivo and Catalytically Induces Angiogenesis via a Basic Fibroblast Growth Factor (FGF-2)/FGFR-2 Pathway
J. Biol. Chem., September 18, 2009; 284(38): 25854 - 25866.
[Abstract] [Full Text] [PDF]

H. W. Smith, P. Marra, and C. J. Marshall
uPAR promotes formation of the p130Cas-Crk complex to activate Rac through DOCK180
J. Cell Biol., August 25, 2008; 182(4): 777 - 790.
[Abstract] [Full Text] [PDF]

C. Lamagna, M. Aurrand-Lions, and B. A. Imhof
Dual role of macrophages in tumor growth and angiogenesis
J. Leukoc. Biol., October 1, 2006; 80(4): 705 - 713.
[Abstract] [Full Text] [PDF]

V. W.M. van Hinsbergh, M. A. Engelse, and P. H.A. Quax
Pericellular Proteases in Angiogenesis and Vasculogenesis
Arterioscler Thromb Vasc Biol, April 1, 2006; 26(4): 716 - 728.
[Abstract] [Full Text] [PDF]

B. Margosio, D. Marchetti, V. Vergani, R. Giavazzi, M. Rusnati, M. Presta, and G. Taraboletti
Thrombospondin 1 as a scavenger for matrix-associated fibroblast growth factor 2
Blood, December 15, 2003; 102(13): 4399 - 4406.
[Abstract] [Full Text] [PDF]

S. R. Harvey, T. C. Hurd, G. Markus, M. I. Martinick, R. M. Penetrante, D. Tan, P. Venkataraman, N. DeSouza, S. N. J. Sait, D. L. Driscoll, et al.
Evaluation of Urinary Plasminogen Activator, Its Receptor, Matrix Metalloproteinase-9, and von Willebrand Factor in Pancreatic Cancer
Clin. Cancer Res., October 15, 2003; 9(13): 4935 - 4943.
[Abstract] [Full Text] [PDF]

S. Stefansson and D. A. Lawrence
Old Dogs and New Tricks, Proteases, Inhibitors, and Cell Migration
Sci. Signal., July 1, 2003; 2003(189): pe24 - pe24.
[Abstract] [Full Text] [PDF]

A. A. Hardikar, B. Marcus-Samuels, E. Geras-Raaka, B. M. Raaka, and M. C. Gershengorn
Human pancreatic precursor cells secrete FGF2 to stimulate clustering into hormone-expressing islet-like cell aggregates
PNAS, June 10, 2003; 100(12): 7117 - 7122.
[Abstract] [Full Text] [PDF]

M. S. Pepper
Role of the Matrix Metalloproteinase and Plasminogen Activator-Plasmin Systems in Angiogenesis
Arterioscler Thromb Vasc Biol, July 1, 2001; 21(7): 1104 - 1117.
[Abstract] [Full Text] [PDF]

R. Giavazzi, R. Giuliani, D. Coltrini, M. R. Bani, C. Ferri, B. Sennino, M. P. M. Tosatti, A. Stoppacciaro, and M. Presta
Modulation of Tumor Angiogenesis by Conditional Expression of Fibroblast Growth Factor-2 Affects Early but not Established Tumors
Cancer Res., January 1, 2001; 61(1): 309 - 317.
[Abstract] [Full Text]

T. L. Frandsen, C. Holst-Hansen, B. S. Nielsen, I. J. Christensen, J. R. Nyengaard, P. Carmeliet, and N. Brünner
Direct Evidence of the Importance of Stromal Urokinase Plasminogen Activator (uPA) in the Growth of an Experimental Human Breast Cancer Using a Combined uPA Gene-Disrupted and Immunodeficient Xenograft Model
Cancer Res., January 1, 2001; 61(2): 532 - 537.
[Abstract] [Full Text]

This Article

Summary

Full Text (PDF)

Alert me when this article is cited

Alert me if a correction is posted

Services

Email this article to a friend

Similar articles in this journal

Similar articles in PubMed

Alert me to new issues of the journal

Download to citation manager

Citing Articles

Citing Articles via HighWire

Citing Articles via Google Scholar

Google Scholar

Articles by Ribatti, D.

Articles by Presta, M.

Search for Related Content

PubMed

PubMed Citation

Articles by Ribatti, D.

Articles by Presta, M.

Social Bookmarking

What's this?

				H. W. Smith, P. Marra, and C. J. Marshall uPAR promotes formation of the p130Cas-Crk complex to activate Rac through DOCK180 J. Cell Biol., August 25, 2008; 182(4): 777 - 790. [Abstract] [Full Text] [PDF]

				C. Lamagna, M. Aurrand-Lions, and B. A. Imhof Dual role of macrophages in tumor growth and angiogenesis J. Leukoc. Biol., October 1, 2006; 80(4): 705 - 713. [Abstract] [Full Text] [PDF]

				V. W.M. van Hinsbergh, M. A. Engelse, and P. H.A. Quax Pericellular Proteases in Angiogenesis and Vasculogenesis Arterioscler Thromb Vasc Biol, April 1, 2006; 26(4): 716 - 728. [Abstract] [Full Text] [PDF]

				B. Margosio, D. Marchetti, V. Vergani, R. Giavazzi, M. Rusnati, M. Presta, and G. Taraboletti Thrombospondin 1 as a scavenger for matrix-associated fibroblast growth factor 2 Blood, December 15, 2003; 102(13): 4399 - 4406. [Abstract] [Full Text] [PDF]

				S. R. Harvey, T. C. Hurd, G. Markus, M. I. Martinick, R. M. Penetrante, D. Tan, P. Venkataraman, N. DeSouza, S. N. J. Sait, D. L. Driscoll, et al. Evaluation of Urinary Plasminogen Activator, Its Receptor, Matrix Metalloproteinase-9, and von Willebrand Factor in Pancreatic Cancer Clin. Cancer Res., October 15, 2003; 9(13): 4935 - 4943. [Abstract] [Full Text] [PDF]

				S. Stefansson and D. A. Lawrence Old Dogs and New Tricks, Proteases, Inhibitors, and Cell Migration Sci. Signal., July 1, 2003; 2003(189): pe24 - pe24. [Abstract] [Full Text] [PDF]

				A. A. Hardikar, B. Marcus-Samuels, E. Geras-Raaka, B. M. Raaka, and M. C. Gershengorn Human pancreatic precursor cells secrete FGF2 to stimulate clustering into hormone-expressing islet-like cell aggregates PNAS, June 10, 2003; 100(12): 7117 - 7122. [Abstract] [Full Text] [PDF]

				M. S. Pepper Role of the Matrix Metalloproteinase and Plasminogen Activator-Plasmin Systems in Angiogenesis Arterioscler Thromb Vasc Biol, July 1, 2001; 21(7): 1104 - 1117. [Abstract] [Full Text] [PDF]

				R. Giavazzi, R. Giuliani, D. Coltrini, M. R. Bani, C. Ferri, B. Sennino, M. P. M. Tosatti, A. Stoppacciaro, and M. Presta Modulation of Tumor Angiogenesis by Conditional Expression of Fibroblast Growth Factor-2 Affects Early but not Established Tumors Cancer Res., January 1, 2001; 61(1): 309 - 317. [Abstract] [Full Text]

				T. L. Frandsen, C. Holst-Hansen, B. S. Nielsen, I. J. Christensen, J. R. Nyengaard, P. Carmeliet, and N. Brünner Direct Evidence of the Importance of Stromal Urokinase Plasminogen Activator (uPA) in the Growth of an Experimental Human Breast Cancer Using a Combined uPA Gene-Disrupted and Immunodeficient Xenograft Model Cancer Res., January 1, 2001; 61(2): 532 - 537. [Abstract] [Full Text]